• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2004 Fiscal Year Final Research Report Summary

Development of novel radiopharmaceuticals for functional imaging of sigma receptors in human brain diseases.

Research Project

Project/Area Number 13670972
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Radiation science
Research InstitutionOsaka University of Pharmaceutical Sciences

Principal Investigator

OHMOMO Yoshiro  Osaka University of Pharmaceutical Sciences, Department Pharmaceutical Sciences, Associate Professor, 薬学部, 助教授 (70183241)

Project Period (FY) 2001 – 2004
KeywordsSigma Receptor / Brain Disease / Radiopharmaceutical / Nuclear Medicine / Diagnostic Imaging / SPECT
Research Abstract

Sigma receptors have been the focus of intense study because of their potential to offer new insights into the mechanism of psychoses, movement disorders, and neurodegeneration. Recently, high densities of sigma receptors have been demonstrated in several tumor-derived cell lines. SPECT and PET radiopharmaceuticals specific for sigma receptors would be of great value as diagnostic tools for movement disorders and certain psychotic illness, and for non-invasive visualization of sigma receptor expressed tumors in vivo.
In the present research, novel radioiodinated ligand [^<125>I]o-BON {1-(2-[^<125>I]iodophenyl-propyl)-4-(3,4-dimethoxyphenylethyl)piperazine} was designed based on structure-activity relationship, synthesized and characterized. [^<125>I]o-BON was found to possess very high affinity and selectivity for sigma receptors.
Furthermore, we investigated brain distribution of [^<125>I]o-BON and compared it with cerebral blood flow (CBF) by using rat model of middle cerebral artery (MCA) occlusion and in vitro autoradiography technique. In the region of an infarct, accumulation of [^<125>I]o-BON decreased concurrently with CBF reduction. However, an increased accumulation of [^<125>I]o-BON relative to CBF was observed in ischemic but vital regions, especially in hippocampus CA1region. These data indicate that [^<125>I]o-BON may provide functional information based on sigma receptors different from CBF, and [^<125>I]o-BON is a potentially useful radiotracer for imaging and evaluating the pathophysiology of cerebral ischemia.

  • Research Products

    (4 results)

All 2003 2002

All Journal Article (4 results)

  • [Journal Article] A new ^<68>Ge/^<68>Ga generator system using an organic polymer containing N-methylglucamine groups as adsorbent for ^<68>Ge.2003

    • Author(s)
      Morio Nakayama
    • Journal Title

      Appl.Radiat.Isot. 58・1

      Pages: 9-14

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] A new ^<86>Ge/^<86>Ga generator system using an organic polymer containing N-methylglucamine groups as adsorbent for ^<86>Ge2003

    • Author(s)
      Morio Nakayama, Yoshiro Ohmomo, et al.
    • Journal Title

      Appl.Radiat.Isot. 58

      Pages: 9-14

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Synthesis and characterization of radioiodinated MD-230254 : a new ligand for potential imaging of monoamine oxidase B activity by single photon emission computed tomography.2002

    • Author(s)
      Masahiko Hirata
    • Journal Title

      Chem.Pharm.Bull. 50・5

      Pages: 609-614

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Synthesis and characterization of radioiodinated MD-230254 : a new ligand for potential imaging of monoamine oxidase B activity by single photon emission computed tomography2002

    • Author(s)
      Masahiko Hirata, Yoshiro Ohmomo, et al.
    • Journal Title

      Chem.Pharm.Bull. 50

      Pages: 609-614

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2006-07-11  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi